Cipla
E744362
Cipla is a major Indian multinational pharmaceutical company known for producing affordable generic medicines and expanding access to essential drugs worldwide.
Statements (76)
| Predicate | Object |
|---|---|
| instanceOf |
pharmaceutical company
ⓘ
public company ⓘ |
| collaboratesWith |
global health organizations
ⓘ
governments ⓘ non-governmental organizations ⓘ |
| countryOfOrigin | India ⓘ |
| engagesIn |
contract manufacturing
ⓘ
export of pharmaceuticals ⓘ research and development ⓘ |
| focusesOn |
HIV/AIDS medicines
ⓘ
active pharmaceutical ingredients ⓘ anti-infective medicines ⓘ branded generics ⓘ cardiovascular medicines ⓘ central nervous system medicines ⓘ dermatology medicines ⓘ diabetes medicines ⓘ generic medicines ⓘ oncology medicines ⓘ respiratory medicines ⓘ urology medicines ⓘ |
| formerName | The Chemical, Industrial & Pharmaceutical Laboratories NERFINISHED ⓘ |
| foundedBy | Khwaja Abdul Hamied NERFINISHED ⓘ |
| foundingLocation |
India
NERFINISHED
ⓘ
Mumbai NERFINISHED ⓘ |
| hasGlobalPresenceIn |
Africa
NERFINISHED
ⓘ
Asia NERFINISHED ⓘ Europe NERFINISHED ⓘ Latin America NERFINISHED ⓘ Middle East NERFINISHED ⓘ North America NERFINISHED ⓘ |
| hasKeyBusinessArea |
HIV/AIDS care
ⓘ
cardiology ⓘ consumer healthcare ⓘ inhalation therapy ⓘ oncology ⓘ respiratory ⓘ women's health ⓘ |
| hasNotableSubsidiary |
Cipla Health
NERFINISHED
ⓘ
Cipla Medpro NERFINISHED ⓘ Cipla USA NERFINISHED ⓘ Exelan Pharmaceuticals NERFINISHED ⓘ InvaGen Pharmaceuticals NERFINISHED ⓘ |
| hasProductType |
capsules
ⓘ
creams ⓘ eye drops ⓘ inhalers ⓘ injectables ⓘ nebulizer solutions ⓘ ointments ⓘ syrups ⓘ tablets ⓘ |
| headquartersLocation |
India
NERFINISHED
ⓘ
Maharashtra NERFINISHED ⓘ Mumbai NERFINISHED ⓘ |
| inception | 1935 ⓘ |
| industry |
biotechnology industry
ⓘ
pharmaceutical industry ⓘ |
| isListedOn |
Bombay Stock Exchange
NERFINISHED
ⓘ
National Stock Exchange of India NERFINISHED ⓘ |
| knownFor |
HIV/AIDS antiretroviral therapies
ⓘ
affordable generic medicines ⓘ expanding access to essential drugs ⓘ |
| operatesIn |
Australia
NERFINISHED
ⓘ
Bangladesh NERFINISHED ⓘ India NERFINISHED ⓘ Nepal NERFINISHED ⓘ South Africa NERFINISHED ⓘ Sri Lanka NERFINISHED ⓘ UAE NERFINISHED ⓘ United Kingdom ⓘ United States of America ⓘ
surface form:
United States
|
| regulatoryApprovalFrom |
European Medicines Agency
NERFINISHED
ⓘ
US Food and Drug Administration NERFINISHED ⓘ World Health Organization Prequalification Programme NERFINISHED ⓘ |
| stockTicker | CIPLA NERFINISHED ⓘ |
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.